长期以来，EGFR 突变 III 期不可切除非小细胞肺癌（NSCLC）患者缺乏有效的创新治疗手段。研究显示，根治性放化疗（CRT）+免疫巩固治疗模式对 EGFR 突变患者的疗效并不理想[1]。然而，EGFR 突变 III 期不可切除 NSCLC ...

EGFR-TKI 的迭代使 EGFR 突变非小细胞肺癌（NSCLC）患者的生存预后得到了极大的改善，但耐药问题仍不可避免。MET 扩增常继发于其他驱动基因阳性 NSCLC 患者靶向治疗后，是 EGFR-TKI 耐药的主要机制之一，因此掌握 ...

This is an audio transcript of the Rachman Review podcast episode: ‘South Korea’s real-life political drama’ Gideon Rachman Hello and welcome to the Rachman Review. I’m Gideon Rachman, chief foreign a ...

SpicyComedy is stand-up in Shanghai featuring some of the funniest local and traveling comedians. With shows held throughout the week at the SpicyComedy Lounge in Xintiandi, audiences are in for an ...